166 related articles for article (PubMed ID: 13695799)
21. [Copper metabolism after living related liver transplantation for Wilson's disease].
Wang XH; Cheng F; Zhang F; Li XC; Li GQ
Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):303. PubMed ID: 15161511
[No Abstract] [Full Text] [Related]
22. [On the therapy of Wilson's disease].
da COSTA S; da SILVA J
Arzneimittelforschung; 1963 Apr; 13():280-2. PubMed ID: 14023283
[No Abstract] [Full Text] [Related]
23. [Present concepts of copper physiology and Wilson's disease].
Cooperberg L; Schuscheim I; Mickevicius AE; FernándezED
Rev Clin Esp; 1968 Dec; 111(5):533-8. PubMed ID: 5732473
[No Abstract] [Full Text] [Related]
24. Brain copperprotein fractions in the normal and in Wilson's disease.
FOLCH J; PORTER H
AMA Arch Neurol Psychiatry; 1957 Jan; 77(1):8-16. PubMed ID: 13381211
[No Abstract] [Full Text] [Related]
25. [Clinical and biochemical aspects in Wilson's disease in several families].
Fukuda K
Shinkei Kenkyu No Shimpo; 1965 Dec; 9(4):817-27. PubMed ID: 5894519
[No Abstract] [Full Text] [Related]
26. [Metabolism of iron and copper, action of chelators and therapeutic possibilities in Wilson's disease and hemochromatosis].
PIRART J
Pathol Biol; 1961 May; 9():1157-74. PubMed ID: 13735975
[No Abstract] [Full Text] [Related]
27. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
[TBL] [Abstract][Full Text] [Related]
28. Studies on hepatolenticular degeneration; copper as the causative agent in the degeneration and dysfunction of electric tissue.
HANSL N; HYMAN I; LUPARELLO T; ZIMDAHL WT
J Lab Clin Med; 1956 Jul; 48(1):108-16. PubMed ID: 13332347
[No Abstract] [Full Text] [Related]
29. A study on the concentrations of serum zinc, non-ceruloplasmin copper, reactive oxygen and nitrogen species in children with Wilson's disease.
Geetha A; Jeyachristy SA; Selvamathy SM; Ilavarasi S; Surendran R
Clin Chim Acta; 2007 Aug; 383(1-2):165-7. PubMed ID: 17573059
[No Abstract] [Full Text] [Related]
30. Neurological presentation of Wilson's disease in a patient after liver transplantation.
Litwin T; Gromadzka G; Członkowska A
Mov Disord; 2008 Apr; 23(5):743-6. PubMed ID: 18181205
[TBL] [Abstract][Full Text] [Related]
31. Copper imbalance and oxidative stress in neurodegeneration.
Rossi L; Arciello M; Capo C; Rotilio G
Ital J Biochem; 2006; 55(3-4):212-21. PubMed ID: 17274527
[TBL] [Abstract][Full Text] [Related]
32. Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper.
Lindquist RR
Arch Pathol; 1969 Apr; 87(4):370-9. PubMed ID: 5766764
[No Abstract] [Full Text] [Related]
33. [Hepatocerebral degeneration (Wilson's disease). I. Pathogenesis, clinical aspects, electroencephalogram].
Werner T; Weinmann H
Med Klin; 1965 Nov; 60(45):1811-6. PubMed ID: 5887817
[No Abstract] [Full Text] [Related]
34. Significance of copper determination in late onset of Wilson's disease.
Lech T; Hydzik P; Kosowski B
Clin Toxicol (Phila); 2007 Sep; 45(6):688-94. PubMed ID: 17849244
[TBL] [Abstract][Full Text] [Related]
35. [Wilson's disease: Clinical presentations].
Chilcott-Lauber C; Burkhard PR; Giostra E
Rev Med Suisse; 2005 Sep; 1(31):2018, 2020-2. PubMed ID: 16212003
[TBL] [Abstract][Full Text] [Related]
36. Liver transplantation for Wilson's disease.
Sevmis S; Karakayali H; Aliosmanoglu I; Yilmaz U; Ozcay F; Torgay A; Arslan G; Haberal M
Transplant Proc; 2008; 40(1):228-30. PubMed ID: 18261593
[TBL] [Abstract][Full Text] [Related]
37. [Metabolic significance of alpha-lipoic acid. IV. Action of alpha-lipoic acid on ceruloplasmin and transferrin in different pathological conditions. (Preliminary report)].
da COSTA S; da SILVA J; MALDONADO FE
Arq Patol; 1963 Apr; 35():3-19. PubMed ID: 14023282
[No Abstract] [Full Text] [Related]
38. COPPER metabolism and amino acid excretion in Wilson's disease.
Nutr Rev; 1954 Oct; 12(10):304-5. PubMed ID: 13203840
[No Abstract] [Full Text] [Related]
39. [WILSON'S DISEASE. HISTORICAL PROGRESS IN ITS STUDY, AND FUTURE RESEARCH WITH SPECIAL REFERENCE TO ABNORMALITIES OF COPPER METABOLISM].
OGIHARA K
Sogo Igaku; 1963 Sep; 20():649-54. PubMed ID: 14057196
[No Abstract] [Full Text] [Related]
40. Wilson's disease.
Bearn AG
Am J Clin Nutr; 1961; 9():695-9. PubMed ID: 13866167
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
